Dec 13, 2025

Featuring perspectives from Dr Gottfried E Konecny, moderated by Dr Stephen “Fred” Divers, including the following topics: 

• Updates in Ovarian Cancer (OC) 2025 — Dr Konecny (0:00)
• Case: A woman in her mid 50s with ovarian cancer and a PALB2 germline mutation — Dr Mulherin (17:15)
• Case: A woman in her early 60s...

Nov 6, 2025

Featuring perspectives from Dr Kathleen N Moore and Dr Matthew A Powell, including the following topics:

• Introduction: A Pan-tumor Perspective on Microsatellite Instability (MSI)-High Disease — Immunotherapy for Localized Disease (0:00)
• Case: A woman in her early 60s with mismatch repair-deficient metastatic...

Aug 20, 2025

Featuring an interview with Dr Shannon N Westin, including the following topics:

• Biomarker testing and utility in ovarian cancer (OC) (0:00)
• Selection of a PARP inhibitor for the treatment of OC (9:18)
• Addition of immunotherapy to up-front treatment of OC (15:50)
• Utility of minimal residual disease and circulating...

Aug 2, 2025

Featuring perspectives from Prof Susana Banerjee and Dr Ursula Matulonis, including the following topics:

• Introduction: Tale of Two Cities — ASCO 2025 (0:00)
• Ovarian Cancer (11:20)
• HER2-Positive Gynecologic Cancers (31:28)
• Endometrial Cancer (40:16)
• Cervical Cancer (51:14)

CME information and select...

Aug 1, 2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Gynecologic Cancers | Faculty Presentation 2: Endometrial Cancer and Cervical Cancer — Susana Banerjee, MBBS, MA, PhD

CME information and select...